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*Calculated using the U.S. Census Bureau’s July 2017 mid-year population estimates (2017). All other incidence rates for Massachusetts are per 100,000 
population, and were calculated using 2010 U.S. Census unless otherwise noted.    
†MMWR March 23, 2018. TB Incidence in the US 2017 
For additional information, please visit our web page: http://www.mass.gov/dph/cdc/tb 
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Tuberculosis - Massachusetts 
In 2017, 210 cases (incidence rate 3.1 per 100,000 residents*) of tuberculosis 
(TB) disease were reported to, and verified by, the Massachusetts Department of 
Public Health. The Massachusetts case rate remains similar to the United States 
(U.S.) national case rate (2.8 per 100,000 residents)†.  While the number of cases 
in 2017 represents a 10.5% increase over the previous year, the first increase in 5 
years and the first time the Massachusetts case rate is higher than the national 
rate, the multi-year trend has been a decline. Comparing the most recent five-year 
period (2013-2017) with the previous period (2008-2012), the average number of 
cases declined 13%, from 227 to 198 per year. Health disparities continue to be 
prominent, with populations born outside the U.S. or experiencing homelessness 
at increased risk for TB. State and local prevention efforts continue to focus on 
these high-risk populations, as well contacts of TB cases. 
 
Race/Ethnicity  
Racial/ethnic minorities are disproportionately affected by TB; 90% of active TB 
disease in 2017 was diagnosed in members of minority groups. The TB case rate 
per 100,000 residents in 2017 was 18.6 among Asian non-Hispanic residents, 
11.7 among black non-Hispanic residents, and 6.2 among Hispanic residents; 
compared with 0.63 among white non-Hispanic residents. Compared with white 
residents, the relative risk for being diagnosed with TB in 2017 was approximately 
66.7 times higher among Asian (95% CI 42.5, 107.0), 33.5 times higher among 
black (95% CI 20.3, 55.1), and 12.0 times higher among Hispanic residents (95% 
CI 6.7, 20.9). 
  
Higher Risk Groups 
Non-U.S. Born (persons born outside the United States and territories): Among 
210 cases of TB in 2017, 184 (88%) were reported in non-U.S. born persons. 125 
(68%) cases were in persons born in one of eleven countries: India (25, 14%), 
Vietnam (22, 12%), Haiti (16, 9%), Cambodia (12, 7%), China (12, 7%), 
Dominican Republic (10, 5%), Philippines (7, 4%), Guatemala (6, 3%), Cabo 
Verde (5, 3%), Ethiopia (5, 3%) and Kenya (5, 3%). The remaining 59 cases 
(32%) occurred in persons born in 54 additional countries. 
 
Children <15 Years of Age: In 2017, 11 cases of TB were diagnosed in children 
under 15 years of age (5% of cases, incidence rate <1/100,000 children under 15 
years old). Seven of the eleven children (64%) were born in the U.S.    
 
Incarcerated in Prison/Jail: In 2017, one case of TB (<1%) was diagnosed in an 
inmate of a correctional facility.  
 
Homeless: Of the 210 cases of TB reported in 2017, eight (4%) were in persons 
experiencing homelessness within the previous year. Five (63%) were U.S.-born 
individuals. 
  
HIV Co-infected (preliminary): Thirteen persons (6%) diagnosed with TB in 2017 
were known to be co-infected with human immunodeficiency virus (HIV). 
 
Drug Resistance 
In 2017, 164 (78%) of the 210 TB cases were bacteriologically confirmed by 
positive culture for Mycobacterium tuberculosis, and had isolates available for 
drug susceptibility testing. Resistance testing was successfully completed on 161 
(98%) of the 164 isolates. 
 
Resistance to one or more anti-TB drugs was detected in 39 (24%) of the 161 
isolates. Resistance to isoniazid (INH), either alone or in combination with other 
agents, was seen in 18%. With MDR-TB increasing worldwide, MDR-TB in 
Massachusetts is carefully monitored and remains a priority of the TB program. 
Characteristics of TB Cases 2017 
(N=210) 
Demographics                              #  (%) 
Sex 
Male     
Female    
 
99 (47%) 
111 (53%) 
Race Ethnicity  
White, non-Hispanic  
Black, non-Hispanic  
Hispanic  
Asian 
Other, non-Hispanic 
 
21 (10%) 
 58 (28%) 
30 (14%) 
 93 (44%) 
8   (4%) 
Origin of Birth  
U.S. born             
Non-U.S. born  
Unknown 
 
26 (12%)    
184 (88%) 
0 (0%) 
Age (years) 
<5 
 5-14 
15-19 
20-24 
25-44     
45-64     
65+  
 
4   (2%) 
7   (3%) 
7   (3%) 
  12  (6%) 
77 (37%) 
57 (27%) 
46 (22%) 
Clinical Presentation (N=210) 
Primary Site of Disease  
Pulmonary             
Extra-pulmonary  
Both             
    
134 (64%) 
56 (27%) 
20 (10%) 
Chest Radiography 
Cavitary disease only           
Miliary disease only 
Cavitary and miliary  
Non-cavitary disease only     
Normal findings 
Not reported 
 
39 (19%) 
6   (3%) 
 2   (1%) 
116 (55%) 
37 (18%) 
10   (5%) 
Higher Risk Groups+ (N=210) 
Non-U.S. born  
Children <15 years of age 
Incarcerated in prison/jail 
Homeless 
Substance use* 
HIV co-infection 
184 (88%) 
  11   (5%) 
1 (<1%) 
  8   (4%) 
   8   (4%) 
    13  (6%) 
Drug Resistance Bacteriologically 
confirmed cases with drug susceptibility 
results (N=161) 
Pattern   
Resistance to at least 1drug 
Resistance to at least INH 
Resistance to at least INH 
and RIF (MDR-TB) 
 
39 (24%) 
29 (18%) 
5   (3%) 
+ Not mutually exclusive groups 
*  Alcohol, injecting and/or non-injecting drug 
use 
 
For additional information, please visit our web page: http://www.mass.gov/dph/cdc/tb 
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TB Drug Resistance, Massachusetts, 2017 
 
 
*TB cases with either a positive sputum culture or a positive culture of 
tissue/other body fluids 
 
 
 
 
 
 
 
*Regions defined using UN classifications  
http://esa.un.org/wpp/Excel-Data/country-classification.pdf 
Drug Resistant TB Cases by Place of 
Birth* Massachusetts, 2017 (N=39) 
*US Born cases include Puerto 
Rico 
TB Cases in US and Non-US Born* Persons, 
Massachusetts, 2007-2017 
*Non US Birth defined as outside the United States and its territories 
Countries of Origin TB Cases, 
Massachusetts, 2017 (N=210) 
Sites of Extra-Pulmonary Disease Only 
Massachusetts, 2017 (n=56) 
 
TB Cases by Site of Disease, 
Massachusetts 2017 (N=210) 
